Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001947317 | SCV002136792 | uncertain significance | 3-methylglutaconic aciduria, type VIIB | 2021-12-03 | criteria provided, single submitter | clinical testing | Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has not been reported in the literature in individuals affected with CLPB-related conditions. This sequence change replaces arginine, which is basic and polar, with serine, which is neutral and polar, at codon 594 of the CLPB protein (p.Arg594Ser). This variant is present in population databases (rs778761751, gnomAD 0.02%). |
Ambry Genetics | RCV002551008 | SCV003645369 | uncertain significance | Inborn genetic diseases | 2022-08-17 | criteria provided, single submitter | clinical testing | The c.1782G>T (p.R594S) alteration is located in exon 16 (coding exon 16) of the CLPB gene. This alteration results from a G to T substitution at nucleotide position 1782, causing the arginine (R) at amino acid position 594 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |